|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
2,970,000 |
Market
Cap: |
1.11(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.3751 - $0.3751 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile OncoSec Medical is a immuno-oncology company focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics to stimulate and to guide anti-tumor immune responses for the treatment of cancers. Co.'s main technology platform ImmunoPulse® is a drug-device therapeutic modality platform comprised of proprietary intratumoral electroporation (EP) delivery devices (the OncoSec Medical System (OMS) EP Device) and a proprietary DNA plasmid. The OMS EP Device is designed to deliver plasmid DNA-encoded drugs into a solid tumor and promote an immunological response against cancer. Co.'s main product candidate is a DNA-encoded interleukin-12 called tavokinogene telseplasmid.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
607 |
Total Sell Value |
$0 |
$0 |
$0 |
$362 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Slansky Richard B |
Chief Financial Officer |
|
2018-06-22 |
4 |
S |
$1.42 |
$9,515 |
D/D |
(6,710) |
301,656 |
|
- |
|
Dhillon Avtar S |
Director |
|
2018-06-22 |
4 |
S |
$1.42 |
$4,192 |
D/D |
(2,956) |
157,505 |
|
- |
|
Dhillon Punit |
Director |
|
2018-06-21 |
4 |
S |
$1.40 |
$15,460 |
D/D |
(11,035) |
601,627 |
|
- |
|
Slansky Richard B |
Chief Financial Officer |
|
2018-06-21 |
4 |
S |
$1.40 |
$6,927 |
D/D |
(4,944) |
308,366 |
|
- |
|
Dhillon Avtar S |
Director |
|
2018-06-21 |
4 |
S |
$1.40 |
$3,051 |
D/D |
(2,178) |
160,461 |
|
- |
|
Dhillon Punit |
Director |
|
2018-06-20 |
4 |
S |
$1.42 |
$79,042 |
D/D |
(55,585) |
612,662 |
|
- |
|
Slansky Richard B |
Chief Financial Officer |
|
2018-06-20 |
4 |
S |
$1.42 |
$35,416 |
D/D |
(24,906) |
313,310 |
|
- |
|
Dhillon Avtar S |
Director |
|
2018-06-20 |
4 |
S |
$1.42 |
$15,604 |
D/D |
(10,973) |
162,639 |
|
- |
|
Dhillon Punit |
Director |
|
2018-06-19 |
4 |
S |
$1.36 |
$12,699 |
D/D |
(9,310) |
668,247 |
|
- |
|
Slansky Richard B |
Chief Financial Officer |
|
2018-06-19 |
4 |
S |
$1.36 |
$5,689 |
D/D |
(4,171) |
338,216 |
|
- |
|
Dhillon Avtar S |
Director |
|
2018-06-19 |
4 |
S |
$1.36 |
$2,507 |
D/D |
(1,838) |
173,612 |
|
- |
|
Dhillon Punit |
Director |
|
2018-06-18 |
4 |
S |
$1.39 |
$39,009 |
D/D |
(28,145) |
677,557 |
|
- |
|
Slansky Richard B |
Chief Financial Officer |
|
2018-06-18 |
4 |
S |
$1.39 |
$17,482 |
D/D |
(12,613) |
342,387 |
|
- |
|
Dhillon Avtar S |
Director |
|
2018-06-18 |
4 |
S |
$1.39 |
$7,695 |
D/D |
(5,552) |
175,450 |
|
- |
|
Dhillon Punit |
Director |
|
2018-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
475,000 |
705,702 |
|
- |
|
Slansky Richard B |
Chief Financial Officer |
|
2018-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
200,000 |
355,000 |
|
- |
|
Dhillon Avtar S |
Director |
|
2018-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
100,000 |
181,002 |
|
- |
|
Dhillon Punit |
President |
|
2018-02-06 |
4/A |
A |
$0.88 |
$2,640 |
D/D |
3,000 |
230,702 |
|
- |
|
Dhillon Punit |
President |
|
2018-02-06 |
4 |
B |
$0.88 |
$2,640 |
I/I |
3,000 |
230,702 |
2.58 |
- |
|
O'connor Daniel |
CEO |
|
2018-02-05 |
4 |
B |
$1.50 |
$25,001 |
D/D |
16,667 |
16,667 |
2.81 |
- |
|
Mohan-Peterson Sheela |
Chief Legal&Compliance Officer |
|
2017-07-31 |
4 |
B |
$0.88 |
$2,640 |
D/D |
3,000 |
9,520 |
2.66 |
- |
|
Dhillon Punit |
President and CEO |
|
2017-07-31 |
4 |
B |
$0.88 |
$2,640 |
I/I |
3,000 |
227,702 |
2.58 |
- |
|
Mohan-Peterson Sheela |
Chief Legal&Compliance Officer |
|
2017-01-31 |
4 |
B |
$0.99 |
$2,970 |
D/D |
3,000 |
6,520 |
2.66 |
- |
|
Dhillon Punit |
President and CEO |
|
2017-01-31 |
4 |
B |
$0.99 |
$2,970 |
I/I |
3,000 |
224,702 |
1.91 |
- |
|
Mohan-Peterson Sheela |
CL&CO |
|
2016-07-31 |
4 |
B |
$1.44 |
$4,320 |
D/D |
3,000 |
153,250 |
2.66 |
- |
|
121 Records found
|
|
Page 4 of 5 |
|
|